(Q27273957)
Statements
735.201±0 dalton
1 reference
111266-55-8 (English)
14 October 2016
C₃₃H₃₇NO₁₈
1 reference
111266-55-8 (English)
14 October 2016
CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O.C(C(=O)O)C(CC(=O)O)(C(=O)O)O
1 reference
111266-55-8 (English)
14 October 2016
C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O.C(C(=O)O)C(CC(=O)O)(C(=O)O)O
1 reference
111266-55-8 (English)
14 October 2016
Identifiers
1 reference
111266-55-8 (English)
14 October 2016
1 reference
111266-55-8 (English)
14 October 2016
2 references
doxorubicin citrate (English)
14 October 2016
1 reference
(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-1-tetracenyl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside 2-hydroxy-1,2,3-propanetricarboxylate (1:1) (English)
14 October 2016
2 references
111266-55-8 (English)
14 October 2016
2 references
doxorubicin citrate (English)
14 October 2016